Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma
1. The median progression-free survival in the metastasis-directed therapy arm was 10.3 months vs 2.5 months in the control arm ...
Tag: pancreatic adenocarcinoma
#VisualAbstract: Treatment with adjuvant mFOLFIRINOX as compared with gemcitabine improves survival outcomes in resected pancreatic cancer
1. Median disease-free survival is longer in patients receiving mFOLFIRINOX as compared to those receiving gemcitabine. 2. Median overall survival ...
Quick Take: Low rates of specialized cancer consultation and cancer-directed therapy for noncurable pancreatic adenocarcinoma
Eighty percent of patients with advanced or metastatic pancreatic adenocarcinoma are not candidates for surgical resection and require noncurative therapy, ...
2 Minute Medicine Rewind June 3, 2019
Ultra-processed food intake and risk of cardiovascular disease: prospective cohort study (NutriNet-Santé) The consumption of ultra-processed food has increased substantially ...
Modified FOLFIRINOX results in longer disease-free survival in metastatic pancreatic cancer patients compared to gemcitabine
1. Randomized control trial of patients with metastatic pancreatic adenocarcinoma demonstrates that adjuvant therapy with a modified FOLFIRINOX regimen results ...
Combined immunotherapy may improve survival in metastatic pancreatic cancer
1. In a phase II trial of 90 patients with metastatic pancreatic adenocarcinoma, the combination of two cancer vaccines, Cy/GVAX ...
Hypoxia biomarker may predict distant recurrence in pancreatic cancer
1. In a cohort of 98 patients diagnosed with pancreatic adenocarcinoma who underwent surgical resection, high levels of hypoxia-inducible factor ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
